| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/11/2007 | EP1218504B1 Gl50 molecules and uses therefor |
| 07/11/2007 | EP1175486B1 Method for the preservation of viruses and mycoplasma |
| 07/11/2007 | EP1153122B1 Maturation of dendritic cells with immune response modifying compounds |
| 07/11/2007 | EP1146889B1 IDENTIFICATION OF SPECIFIC DIFFERENTIALLY EXPRESSED MYCOBACTERIAL ANTIGENS AND MEDICAL USE OF THE MYCOBACTERIAL PROTEINS Rv0068 AND Rv3407 |
| 07/11/2007 | EP1037917B1 Recombinant nodavirus compositions and methods |
| 07/11/2007 | EP0979246B1 Human monoclonal antibodies to epidermal growth factor receptor |
| 07/11/2007 | EP0808367B1 Mucosal vascular addressins and uses thereof |
| 07/11/2007 | EP0577752B2 Human pf4a receptors and their use |
| 07/11/2007 | CN1997897A Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators |
| 07/11/2007 | CN1997751A Antibodies and related molecules that bind to PSCA proteins |
| 07/11/2007 | CN1997741A Novel mite allergen |
| 07/11/2007 | CN1997669A Monoclonal antibodies to gastrin hormone |
| 07/11/2007 | CN1997668A Immunoglobulins |
| 07/11/2007 | CN1997667A Humanized FcgammaRIIB-specific antibodies and methods of use thereof |
| 07/11/2007 | CN1997663A Polypeptides from non-typeable haemophilus influenzae |
| 07/11/2007 | CN1997662A Inhibitors based on fusion, HR1 and HR2 sequences in bacterial adhesin |
| 07/11/2007 | CN1997395A Drug having regulatory cell ligand contained in liposome |
| 07/11/2007 | CN1997394A Compositions and methods comprising an EGFL7 antagonist for modulating vascular development |
| 07/11/2007 | CN1997393A Intracellular complexes as biomarkers |
| 07/11/2007 | CN1997392A Neisseria meningitidis igtB LOS as adjuvant |
| 07/11/2007 | CN1997391A Polyinosinic acid-polycytidylic acid-based adjuvant |
| 07/11/2007 | CN1997390A Microfluidized oil-in-water emulsions and vaccine compositions |
| 07/11/2007 | CN1997389A Needle-free administration of felv vaccines |
| 07/11/2007 | CN1997388A Mucinous glycoprotein (MUC-1) vaccine |
| 07/11/2007 | CN1997386A Methods of treating type I diabetes by blocking VEGF-mediated activity |
| 07/11/2007 | CN1997385A Annexin V for preventing atherothrombois and plaque rupture |
| 07/11/2007 | CN1997382A Bispecific binding agents for modulating biological activity |
| 07/11/2007 | CN1997365A Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody |
| 07/11/2007 | CN1997355A Pulmonary malarial vaccine |
| 07/11/2007 | CN1997352A Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| 07/11/2007 | CN1996017A Method for preparing chloromycetin and granular cell coupled complex |
| 07/11/2007 | CN1996016A Method for preparing chloromycetin artificial antigen |
| 07/11/2007 | CN1995352A Mycobacterium tuberculosis cold-shock protein and its uses |
| 07/11/2007 | CN1995340A Mycobacterium tuberculosis glucosamine-6-phosphate synthase gene and its uses |
| 07/11/2007 | CN1995335A Tubercle bacillus rhodanase and its uses |
| 07/11/2007 | CN1995331A Baby pig hydropsy colon bacius gene mutant and its construction method |
| 07/11/2007 | CN1994470A Genetic engineering polypeptide vaccine adjuvant for aftosa, preparation method and application thereof |
| 07/11/2007 | CN1994465A CCR5 autogenous polypeptide vaccine and preparation method thereof |
| 07/11/2007 | CN1325646C Modified nucleic acid sequences and method for increasing mRNA levels and protein expression in cell systems |
| 07/11/2007 | CN1325645C Histamine and serotonin binding molecules |
| 07/11/2007 | CN1325517C Anti hepatitis C virus antibody and uses thereof |
| 07/11/2007 | CN1325512C Fusion protein of HIV regulatory/accessory proteins |
| 07/11/2007 | CN1325117C 联合疫苗组合物 Combined vaccine composition |
| 07/11/2007 | CN1325115C Methods for CTL and T helper cell in therapeutic vaccination |
| 07/10/2007 | US7241877 Humanised antibodies |
| 07/10/2007 | US7241876 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/10/2007 | US7241873 Recombinant anti-osteopontin antibody and use thereof |
| 07/10/2007 | US7241872 Antibody for use as diagnostic and therapeutic tool in genetic engineering |
| 07/10/2007 | US7241869 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 07/10/2007 | US7241867 Polypeptide encoded by a nucleotide sequence of a nontypeable strain of Haemophilus influenzae genome |
| 07/10/2007 | US7241742 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders |
| 07/10/2007 | US7241739 Contacting Bone Morphogenic Protein with human Cerberus protein to antagonize the function of a Bone Moarphogenic Protein or induce neural development |
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241605 Polypeptide |
| 07/10/2007 | US7241592 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
| 07/10/2007 | US7241568 Treating a disease by administering to human or animal said antibody that inhibits the activity of FGF-8; treating prostate cancer, breast cancer or ovarian cancer |
| 07/10/2007 | US7241450 DNA sequence and recombinant production of a Gramineae allergen |
| 07/10/2007 | US7241449 Recombinant Tbp2 protein of Moraxella catarrhalis strain M35, 3 or LES1, used in diagnostics and in vaccines |
| 07/10/2007 | US7241448 T helper cell epitopes |
| 07/10/2007 | US7241447 Adeno-associated virus vectors and uses thereof |
| 07/10/2007 | US7241446 Methods for modulating angiogenesis via VEGF |
| 07/10/2007 | US7241445 Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 07/10/2007 | US7241444 Anti-IGF-IR antibodies and uses thereof |
| 07/10/2007 | US7241443 Functions by preventing attachment or adherence of colony forming immunogens in rumen and intestinal tracts of host food animals; made by inoculating female birds with immunogen, harvesting eggs which contain antibodies, adding to feed |
| 07/10/2007 | US7241441 by activating macrophages/spleen cells and inducing gut immunity; food additive, intestinal function-controlling agent, live bacterial agent, feed additive and other fermented products |
| 07/10/2007 | US7241440 Identifying a subject in need of an increase in titer of IgG antibodies that are specific for a viral antigen; providing an immunogenic composition comprising ribavirin and a nucleic acid molecule encoding viral antigen. |
| 07/10/2007 | US7241438 Interleukin protein for use as tool in identifying modulators of prevention and treatment of disorders associated with inflammatory response |
| 07/10/2007 | CA2366072C Prrsv vaccines |
| 07/10/2007 | CA2283564C Pharmaceutical compositions having appetite suppressant activity |
| 07/10/2007 | CA2203129C Creating an aerosolized formulation of insulin |
| 07/10/2007 | CA2162149C Antibodies to p-selectin and their uses |
| 07/10/2007 | CA2124769C Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/10/2007 | CA2108466C Hcv genomic sequences for diagnostics and therapeutics |
| 07/10/2007 | CA2064604C Method for inhibiting pulmonary oxygen toxicity |
| 07/10/2007 | CA2007248C Meningococcal class 1 outer-membrane protein vaccine |
| 07/10/2007 | CA2001737C Liposome immunoadjuvants containing il-2 |
| 07/05/2007 | WO2007076520A2 Multivalent pcv2 immunogenic compositions and methods of producing such compositions |
| 07/05/2007 | WO2007076465A2 Cln248 antibody compositions and methods of use |
| 07/05/2007 | WO2007076391A1 Tgf-beta binding compositions |
| 07/05/2007 | WO2007076371A2 Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| 07/05/2007 | WO2007076336A1 Treatment of migraine with anti-cgrp antibodies |
| 07/05/2007 | WO2007076200A2 Antagonists of hmgb1 and/or rage and methods of use thereof |
| 07/05/2007 | WO2007076091A2 Treatment of viral infections using a tissue factor inhibitor |
| 07/05/2007 | WO2007075921A2 De-n-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy |
| 07/05/2007 | WO2007075915A2 Monoclonal antibodies against orthopoxviruses |
| 07/05/2007 | WO2007075414A2 Chemically derivatized cd4 and uses thereof |
| 07/05/2007 | WO2007075342A2 Vaccine adjuvant |
| 07/05/2007 | WO2007075335A2 Modulation of in utero immune programming |
| 07/05/2007 | WO2007075326A2 Methods of using cd40 binding agents |
| 07/05/2007 | WO2007075308A2 Vaccine candidates against johne's disease |
| 07/05/2007 | WO2007075270A2 Multivalent immunoglobulin-based bioactive assemblies |
| 07/05/2007 | WO2007075120A1 Method for producing a stable aqueous solution of a product containing active substances and a product (variants) |
| 07/05/2007 | WO2007074880A1 Antibody-containing stabilizing preparation |
| 07/05/2007 | WO2007074859A1 Anti-c-mannosylated peptide antibody and use thereof |
| 07/05/2007 | WO2007073914A1 Avirulent isolate of neospora caninum and its uses |
| 07/05/2007 | WO2007073907A1 Hypoallergenic variants of the major allergen from betula verrucosa pollen |
| 07/05/2007 | WO2007073768A1 Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof |
| 07/05/2007 | WO2007059979A3 Allergy treatment by epicutaneous allergen administration |
| 07/05/2007 | WO2007057490A3 Immunogenic polypeptides of presenilin-1-associated protein (psap), methods of obtaining antibodies and use of same |